The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT.

Saved in:
Bibliographic Details
Title: The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT.
Authors: Güven M; Department of Internal Medicine, Ankara Bilkent City Hospital, Ankara, Turkey. guvenmd@gmail.com., Peczynski C; EBMT Paris Study Unit, Department of Haematology, Saint Antoine Hospital, INSERM UMR-S 938, Sorbonne University, Paris, France.; Transplant Complications Working Party of EBMT, Marseille, France., Boreland W; EBMT Paris Study Unit, Department of Haematology, Saint Antoine Hospital, INSERM UMR-S 938, Sorbonne University, Paris, France.; Transplant Complications Working Party of EBMT, Marseille, France., Blaise D; Transplantation & Cellular Therapy, Department of Hematology, Institut Paoli Calmettes, Management Sport Cancer Lab, Luminy, Aix Marseille University, Marseille, France., Peffault de Latour R; Saint-Louis Hospital, BMT Unit, Paris, France., Yakoub-Agha I; CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France., Gedde-Dahl T; Oslo University Hospital, Rikshospitalet, Oslo, Norway., Salmenniemi U; HUCH Comprehensive Cancer Center, Helsinki, Finland., Forcade E; CHU Bordeaux, Hopital Haut-Leveque, Pessac, France., Passweg J; University Hospital Basel, Basel, Switzerland., Chevallier P; CHU Nantes, Nantes, France., Sandrine L; Centre Hospitalier Lyon Sud, Lyon, France., Mielke S; Karolinska University Hospital, Stockholm, Sweden., Broers A; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Ceballos P; CHU Saint Eloi, Montpellier, France., Byrne J; Nottingham City Hospital, Nottingham, UK., Castilla-Llorente C; Gustave Roussy Cancer Campus, Villejuif, France., Maertens J; University Hospital Gasthuisberg, Leuven, Belgium., Huynh A; CHU - Institut Universitaire du Cancer Toulouse, Toulouse, France., Cerretti R; Tor Vergata University of Rome, Rome, Italy., Bulabois CE; CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France., van Gorkom G; University Hospital Maastricht, Maastricht, Netherlands., Crawley C; Addenbrookes Hospital Cambridge, Cambridge, UK., Graham C; Comprehensive Cancer Centre, King's College London, London, UK., Mussetti A; Hematology Department, Institut Catala d'Oncologia, Hospital Duran i Reynals, L'Hospitalet De Llobregat, IDIBELL Universitat de Barcelona, Barcelona, Spain., Schoemans H; University Hospital Gasthuisberg, Leuven, Belgium., Penack O; Medical Clinic, Department for Haematology, Oncology and Tumorimmunology, Charité Universitätsmedizin Berlin, Berlin, Germany., Moiseev I; RM Gorbacheva Research Institute, Pavlov University, St Petersburg, Russia., Peric Z; Department of Hematology, Rijeka University Hospital Centre, Rijeka, Croatia.
Source: Bone marrow transplantation [Bone Marrow Transplant] 2025 Jul; Vol. 60 (7), pp. 956-963. Date of Electronic Publication: 2025 Apr 17.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5365
DOI:10.1038/s41409-025-02580-8